Davis Margaret L, Hall Jane, Taylor R Andrew, Klemisch Robert, Farjah Farhood, Hall M Kennedy
Department of Emergency Medicine, University of Washington, Seattle, Washington, USA.
Department of Emergency Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
J Am Coll Emerg Physicians Open. 2025 Jul 2;6(4):100209. doi: 10.1016/j.acepjo.2025.100209. eCollection 2025 Aug.
Primary spontaneous pneumothorax (PSP) is a common emergency condition among healthy individuals that presents significant management challenges, particularly in cases of moderate-to-large collapse, which have traditionally required intervention. Recent trials, including a landmark-randomized trial, have demonstrated effectiveness in 4 separate strategies: (1) observation only, (2) needle aspiration, (3) small-bore chest tubes with a 1-way valve, and (4) small-bore chest tubes with continuous suction. We compare the cost-effectiveness of these 4 strategies.
We conducted a cost-effectiveness analysis from a US healthcare system perspective to compare 4 management strategies for moderate-to-large PSP in stable adult emergency department patients. Using published randomized controlled trials and secondary data, we developed a decision-analytic model with a lifetime horizon. Costs (2022 USD), quality-adjusted life-years, and net monetary benefit (NMB) were calculated at a $50,000/quality-adjusted life-years willingness-to-pay threshold and 3% annual discount. We performed 1-way and probabilistic sensitivity analyses to test the robustness of findings.
Base case analysis identified observation only as the most cost-effective strategy, achieving the highest NMB ($43,696). The NMB values for small-bore chest tubes with a 1-way valve, needle aspiration, and small-bore chest tube with continuous suction were $33,520, $29,465, and $12,831, respectively. Sensitivity analyses indicated that factors such as initial success rates for observation and needle aspiration influenced model outcomes, whereas probabilistic simulations confirmed observation only as the dominant strategy.
Observation alone is the most cost-effective initial strategy for stable moderate-to-large PSP, although its feasibility may be limited. Among interventional options, a small-bore chest tube with a 1-way valve offers the best value and enables outpatient management. Further studies in diverse settings are needed to confirm the practicality of observation only care and consider individual patient factors.
原发性自发性气胸(PSP)是健康个体中常见的急症,给治疗带来了重大挑战,尤其是在中至大量肺萎陷的情况下,传统上这类情况需要进行干预。最近的试验,包括一项具有里程碑意义的随机试验,已证明4种不同策略的有效性:(1)仅观察,(2)针吸,(3)带单向阀的细胸管,以及(4)持续吸引的细胸管。我们比较这4种策略的成本效益。
我们从美国医疗系统的角度进行了成本效益分析,以比较稳定的成年急诊科患者中至大量PSP的4种治疗策略。利用已发表的随机对照试验和二手数据,我们建立了一个具有终身视野的决策分析模型。成本(2022美元)、质量调整生命年和净货币效益(NMB)是在50,000美元/质量调整生命年的支付意愿阈值和3%的年贴现率下计算的。我们进行了单因素和概率敏感性分析,以检验研究结果的稳健性。
基础病例分析确定仅观察是最具成本效益的策略,实现了最高的NMB(43,696美元)。带单向阀的细胸管、针吸和持续吸引的细胸管的NMB值分别为33,520美元、29,465美元和12,831美元。敏感性分析表明,观察和针吸的初始成功率等因素会影响模型结果,而概率模拟证实仅观察是主导策略。
对于稳定的中至大量PSP,仅观察是最具成本效益的初始策略,尽管其可行性可能有限。在介入选项中,带单向阀的细胸管提供了最佳价值,并能实现门诊治疗。需要在不同环境中进行进一步研究,以确认仅观察治疗的实用性,并考虑个体患者因素。